home / lobbying / lobbying_activities

lobbying_activities: 3492021

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3492021 dbc99f25-c3f7-4395-ba27-72f5713dfa35 Q4 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2025 fourth_quarter INS Advocated for increased FY26 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY26 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for reintroduction of Residential Recovery for Seniors Act. This first-of-its-kind legislation would create a Medicare Part A benefit for residential addiction treatment programs meeting nationally recognized standards, categorized as Level 3.1: Clinically Managed Low-intensity Residential Treatment; Level 3.5: Clinically Managed High-intensity Residential Treatment, and/or Level 3.7: Medically Managed Residential Treatment. It would also establish a prospective payment system for these programs, ensuring that reimbursement for covered residential addiction treatment services is based on pre-determined, fixed amounts. Advocated for reintroduction of S. 644 - the Modernizing Opioid Treatment Access Act, which would allow specially registered addiction specialist physicians to prescribe methadone for OUD that could be accessed at pharmacies. Joined coalition letter to HHS Secretary Robert F. Kennedy, Jr., calling for the agency to allow flexible state implementation of H.R. 1s Community Engagement provisions, consistent with the clear statutory direction, related to exemption verifications. Joined coalition letter to CMS for a generous Medicaid work requirement exemptions for people with substance use disorder and disabling mental health conditions. Advocated in meeting with CMS for a generous Medicaid work requirement exemption for people with substance use disorder. Sent ASAMs statement on marijuana rescheduling to ONDCP Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   70000 0 0 2026-01-17T15:49:45-05:00
Powered by Datasette · Queries took 0.394ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API